Hamamoto B

References (2)

Title : Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development - McReynolds_2021_Molecules_26_
Author(s) : McReynolds CB , Yang J , Guedes A , Morisseau C , Garcia R , Knych H , Tearney C , Hamamoto B , Hwang SH , Wagner K , Hammock BD
Ref : Molecules , 26 : , 2021
Abstract : McReynolds_2021_Molecules_26_
ESTHER : McReynolds_2021_Molecules_26_
PubMedSearch : McReynolds_2021_Molecules_26_
PubMedID: 34443621

Title : Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine - Shihadih_2020_Front.Vet.Sci_7_580
Author(s) : Shihadih DS , Harris TR , Kodani SD , Hwang SH , Lee KSS , Mavangira V , Hamamoto B , Guedes A , Hammock BD , Morisseau C
Ref : Front Vet Sci , 7 :580 , 2020
Abstract : Shihadih_2020_Front.Vet.Sci_7_580
ESTHER : Shihadih_2020_Front.Vet.Sci_7_580
PubMedSearch : Shihadih_2020_Front.Vet.Sci_7_580
PubMedID: 33005645